Our mission is to discover new ways to improve and extend people's lives.
We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to provide a shareholder return that rewards those who invest their money, time and ideas in our company.
Our vision is to support people with cancer through innovation and community
More than a decade ago, Novartis AG was the first company to form a dedicated global business unit to develop and launch innovative oncology medicines that address the unmet medical needs of people with cancer and related diseases.
Today, Novartis Oncology – with more than 10,000 associates in 85 countries – is inspired by patients to revolutionize the research, development and manufacturing of innovative, high-quality medicines that help people live longer, with a better quality of life, giving more time to do the things that matter to them. To do our best for patients, we do not accept the status quo. We work to reach more patients worldwide so that patients and society can benefit as quickly as possible.
More than ever, Novartis Oncology has a truly global reach. We have the advantage of extraordinarily talented and globally diverse employees who, through shared goals and different perspectives, are dedicated to helping improve the lives of cancer patients around the world. We now offer an unmatched portfolio of 22 oncology, hematology and rare disease medicines to treat more than 25 conditions worldwide. Our broad pipeline with over 30 new molecular entities in development enables us to change the practice of medicine, and to bring more breakthroughs with real benefits to patients and society.
We continually challenge ourselves to the highest standards of compliance, integrity and performance in all that we do to ensure a sustainable future of innovation for patients, society and Novartis.